Published in World J Gastroenterol on January 14, 2014
The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry (2014) 0.88
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Neuroimaging the brain-gut axis in patients with irritable bowel syndrome. World J Gastrointest Pharmacol Ther (2016) 0.76
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science (2005) 20.51
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 16.84
Effect of in utero and early-life conditions on adult health and disease. N Engl J Med (2008) 14.46
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science (2009) 10.30
A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology (2013) 8.37
The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology. Eur Arch Psychiatry Clin Neurosci (2005) 7.21
Gene regulation by transcription factors and microRNAs. Science (2008) 5.07
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature (2011) 4.34
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature (2011) 3.60
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology (2010) 3.32
The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology (2000) 3.25
Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health. Trends Mol Med (2007) 2.92
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain (2009) 2.74
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut (2009) 2.39
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology (2006) 2.28
The social environment and the epigenome. Environ Mol Mutagen (2008) 2.18
Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. Am J Physiol Gastrointest Liver Physiol (2002) 2.10
First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum Mol Genet (2008) 1.98
Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology (2006) 1.85
Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease. Physiol Rev (2007) 1.79
Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study. Am J Clin Nutr (2007) 1.65
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut (1998) 1.62
Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. J Clin Gastroenterol (2011) 1.60
Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut (2003) 1.58
Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut (2004) 1.55
Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog Neurobiol (2008) 1.53
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci (2013) 1.52
A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest (2012) 1.43
The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. Int J Clin Pract (2013) 1.37
Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology (2009) 1.33
The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci (2007) 1.32
Irritable bowel syndrome: towards biomarker identification. Trends Mol Med (2009) 1.29
Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans. Am J Physiol Gastrointest Liver Physiol (2001) 1.28
Neonatal maternal separation causes colonic dysfunction in rat pups including impaired host resistance. Pediatr Res (2005) 1.28
MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling. Cancer Res (2012) 1.24
Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol (2007) 1.24
Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review. Am J Gastroenterol (2010) 1.23
Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res (2008) 1.22
Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. Genes Immun (2012) 1.16
Food: the forgotten factor in the irritable bowel syndrome. Gastroenterol Clin North Am (2011) 1.15
Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome. Biol Res Nurs (2007) 1.14
Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? Aliment Pharmacol Ther (2010) 1.14
The genetics of irritable bowel syndrome. Clin Gastroenterol Hepatol (2005) 1.12
Diet and rheumatoid arthritis: a review of the literature. Semin Arthritis Rheum (2005) 1.10
Epigenetics and the nervous system. Ann Neurol (2008) 1.09
G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome. Neurogastroenterol Motil (2010) 1.09
Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res (2006) 1.07
Irritable bowel syndrome: role of food in pathogenesis and management. J Dig Dis (2009) 1.06
5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. Eur J Gastroenterol Hepatol (2010) 1.04
Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome. J Clin Immunol (2009) 1.01
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol (2009) 1.00
Not really identical: epigenetic differences in monozygotic twins and implications for twin studies in psychiatry. Am J Med Genet C Semin Med Genet (2009) 0.99
Mechanisms of disease: genetics of functional gastrointestinal disorders--searching the genes that matter. Nat Clin Pract Gastroenterol Hepatol (2007) 0.96
The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci (2009) 0.95
Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome. Gastroenterology (2011) 0.94
T-helper 1, T-helper 2, and T-regulatory cytokines gene polymorphisms in irritable bowel syndrome. Inflammation (2010) 0.93
The relationship between somatisation and outcome in patients with severe irritable bowel syndrome. J Psychosom Res (2008) 0.92
Scope of the problem of functional digestive disorders. Eur J Surg Suppl (1998) 0.92
Nutritional genomics in practice: where do we begin? J Am Diet Assoc (2005) 0.89
The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome. PLoS One (2011) 0.89
Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome. PLoS One (2012) 0.88
Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil (2012) 0.88
Association of alpha 2A adrenergic receptor gene (ADRAlpha2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis. Clin Chim Acta (2009) 0.88
Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea. Neurogastroenterol Motil (2012) 0.87
The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci (2012) 0.87
Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits. Am J Physiol Gastrointest Liver Physiol (2013) 0.87
Does our food (environment) change our gut microbiome ('in-vironment'): a potential role for inflammatory bowel disease? Dig Dis (2013) 0.84
IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol (2010) 0.83
MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field. Int J Neuropsychopharmacol (2009) 0.81
Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease. Mutat Res (2007) 0.81
Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome. Mol Biol Rep (2012) 0.80
[Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders]. Recenti Prog Med (2007) 0.80
Nutrigenomics and nutrigenetics in inflammatory bowel diseases. J Clin Gastroenterol (2012) 0.79
Nutrigenomics and gut health. Mutat Res (2007) 0.77
Food allergy, coeliac disease and chronic inflammatory bowel disease in man. Vet Q (1998) 0.76